Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: XENE) Delayed: 59.27 -0.28 (0.47%)
Previous Close $59.55    52 Week High $9.75 
Open $59.04    52 Week Low $5.65 
Day High $59.81    P/E N/A 
Day Low $59.00    EPS $0.00 
Volume 35,316